Benzinga - by Benzinga Insights, Benzinga Staff Writer.
In a recent SEC filing, it was disclosed that Kimberly Nelson, Director at Colgate-Palmolive (NYSE:CL), made a noteworthy acquisition of company stock options on May 15,.
What Happened: Disclosed in a Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission, Nelson, Director at Colgate-Palmolive, made a strategic derivative acquisition. This involved acquiring stock options for 2,201 shares of CL, providing the right to buy the company's stock at an exercise price of $94.46 per share.
The latest update on Thursday morning shows Colgate-Palmolive shares up by 0.19%, trading at $94.71. At this price, Nelson's 2,201 shares are worth $550.
Get to Know Colgate-Palmolive Better Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's, which primarily sells its products through veterinarians and specialty pet retailers.
Unraveling the Financial Story of Colgate-Palmolive Revenue Growth: Colgate-Palmolive's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 6.18%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Key Insights into Profitability Metrics:
- Gross Margin: With a high gross margin of 60.0%, the company demonstrates effective cost control and strong profitability relative to its peers.
- Earnings per Share (EPS): With an EPS below industry norms, Colgate-Palmolive exhibits below-average bottom-line performance with a current EPS of 0.83.
Financial Valuation Breakdown:
- Price to Earnings (P/E) Ratio: Colgate-Palmolive's P/E ratio of 30.01 is below the industry average, suggesting the stock may be undervalued.
- Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 3.96, Colgate-Palmolive's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
- EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Boasting an EV/EBITDA ratio of 19.33, Colgate-Palmolive demonstrates a robust market valuation, outperforming industry benchmarks.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Exploring the Significance of Insider Trading Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
Important Transaction Codes In the domain of transactions, investors frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of Colgate-Palmolive's Insider Trades.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.